85 related articles for article (PubMed ID: 20683002)
1. Comprehensive analysis of genes involved in the malignancy of gastrointestinal stromal tumors.
Tsumuraya M; Kato H; Miyachi K; Sasaki K; Tsubaki M; Akimoto K; Sunagawa M
Anticancer Res; 2010 Jul; 30(7):2705-15. PubMed ID: 20683002
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
Miettinen M; Sobin LH; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
[TBL] [Abstract][Full Text] [Related]
3. The location of KIT and PDGFRA gene mutations in gastrointestinal stromal tumours is site and phenotype associated.
Penzel R; Aulmann S; Moock M; Schwarzbach M; Rieker RJ; Mechtersheimer G
J Clin Pathol; 2005 Jun; 58(6):634-9. PubMed ID: 15917417
[TBL] [Abstract][Full Text] [Related]
4. Multiple sporadic gastrointestinal stromal tumors (GISTs) of the proximal stomach are caused by different somatic KIT mutations suggesting a field effect.
Agaimy A; Dirnhofer S; Wünsch PH; Terracciano LM; Tornillo L; Bihl MP
Am J Surg Pathol; 2008 Oct; 32(10):1553-9. PubMed ID: 18724245
[TBL] [Abstract][Full Text] [Related]
5. Genetic and pathologic characteristics of gastrointestinal stromal tumors in extragastric lesions.
Cho S; Kitadai Y; Yoshida S; Tanaka S; Yoshihara M; Yoshida K; Chayama K
Int J Mol Med; 2006 Dec; 18(6):1067-71. PubMed ID: 17089009
[TBL] [Abstract][Full Text] [Related]
6. The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST).
Du CY; Shi YQ; Zhou Y; Fu H; Zhao G
J Surg Oncol; 2008 Sep; 98(3):175-8. PubMed ID: 18618605
[TBL] [Abstract][Full Text] [Related]
7. KIT codon 558 insertions in gastrointestinal stromal tumors. Analysis of 17 rare KIT mutants.
Lasota J; Kuban W; Wardelmann E; Debiec-Rychter M; Merkelbach-Bruse S; Sciot R; Rys J; Steigen SE; Iwanik K; Holden JA; Jerzak Vel Dobosz A; Schildhaus HU; Miettinen M
Hum Pathol; 2008 Dec; 39(12):1728-36. PubMed ID: 18715619
[TBL] [Abstract][Full Text] [Related]
8. Familial gastrointestinal stromal tumor syndrome: phenotypic and molecular features in a kindred.
Li FP; Fletcher JA; Heinrich MC; Garber JE; Sallan SE; Curiel-Lewandrowski C; Duensing A; van de Rijn M; Schnipper LE; Demetri GD
J Clin Oncol; 2005 Apr; 23(12):2735-43. PubMed ID: 15837988
[TBL] [Abstract][Full Text] [Related]
9. Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy.
Keun Park C; Lee EJ; Kim M; Lim HY; Choi DI; Noh JH; Sohn TS; Kim S; Kim MJ; Lee HK; Kim KM
Ann Surg; 2008 Jun; 247(6):1011-8. PubMed ID: 18520229
[TBL] [Abstract][Full Text] [Related]
10. Gene expression in gastrointestinal stromal tumors is distinguished by KIT genotype and anatomic site.
Antonescu CR; Viale A; Sarran L; Tschernyavsky SJ; Gonen M; Segal NH; Maki RG; Socci ND; DeMatteo RP; Besmer P
Clin Cancer Res; 2004 May; 10(10):3282-90. PubMed ID: 15161681
[TBL] [Abstract][Full Text] [Related]
11. Frequent c-Kit gene mutations not only in gastrointestinal stromal tumors but also in interstitial cells of Cajal in surrounding normal mucosa.
Ogasawara N; Tsukamoto T; Inada K; Mizoshita T; Ban N; Yamao K; Joh T; Itoh M; Tatematsu M
Cancer Lett; 2005 Dec; 230(2):199-210. PubMed ID: 16297706
[TBL] [Abstract][Full Text] [Related]
12. [Status and clinical analysis of c-kit and PDGFRA mutations in the gastrointestinal stromal tumors].
Du CY; Shi YQ; Zhou Y; Fu H; Zhao GF
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul; 11(4):371-5. PubMed ID: 18636362
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
Lee HE; Kim MA; Lee HS; Lee BL; Kim WH
J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383
[TBL] [Abstract][Full Text] [Related]
14. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor.
Zheng S; Chen LR; Wang HJ; Chen SZ
Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649
[TBL] [Abstract][Full Text] [Related]
15. Microarray analysis identifies versican and CD9 as potent prognostic markers in gastric gastrointestinal stromal tumors.
Setoguchi T; Kikuchi H; Yamamoto M; Baba M; Ohta M; Kamiya K; Tanaka T; Baba S; Goto-Inoue N; Setou M; Sasaki T; Mori H; Sugimura H; Konno H
Cancer Sci; 2011 Apr; 102(4):883-9. PubMed ID: 21244575
[TBL] [Abstract][Full Text] [Related]
16. [Gastrointestinal stromal tumors carrying PDGFRalpha mutations occur preferentially in the stomach and exhibit an epithelioid or mixed phenotype].
Wardelmann E; Pauls K; Merkelbach-Bruse S; Hrychyk A; Losen I; Hohenberger P; Büttner R; Pietsch T
Verh Dtsch Ges Pathol; 2004; 88():174-83. PubMed ID: 16892550
[TBL] [Abstract][Full Text] [Related]
17. Increased KIT signalling with up-regulation of cyclin D correlates to accelerated proliferation and shorter disease-free survival in gastrointestinal stromal tumours (GISTs) with KIT exon 11 deletions.
Haller F; Löbke C; Ruschhaupt M; Schulten HJ; Schwager S; Gunawan B; Armbrust T; Langer C; Ramadori G; Sültmann H; Poustka A; Korf U; Füzesi L
J Pathol; 2008 Oct; 216(2):225-35. PubMed ID: 18729075
[TBL] [Abstract][Full Text] [Related]
18. Array CGH analysis in primary gastrointestinal stromal tumors: cytogenetic profile correlates with anatomic site and tumor aggressiveness, irrespective of mutational status.
Wozniak A; Sciot R; Guillou L; Pauwels P; Wasag B; Stul M; Vermeesch JR; Vandenberghe P; Limon J; Debiec-Rychter M
Genes Chromosomes Cancer; 2007 Mar; 46(3):261-76. PubMed ID: 17171690
[TBL] [Abstract][Full Text] [Related]
19. Deletion of the KIT gene is associated with liver metastasis and poor prognosis in patients with gastrointestinal stromal tumor in the stomach.
Cho S; Kitadai Y; Yoshida S; Tanaka S; Yoshihara M; Yoshida K; Chayama K
Int J Oncol; 2006 Jun; 28(6):1361-7. PubMed ID: 16685437
[TBL] [Abstract][Full Text] [Related]
20. 9p21 locus analysis in high-risk gastrointestinal stromal tumors characterized for c-kit and platelet-derived growth factor receptor alpha gene alterations.
Perrone F; Tamborini E; Dagrada GP; Colombo F; Bonadiman L; Albertini V; Lagonigro MS; Gabanti E; Caramuta S; Greco A; Torre GD; Gronchi A; Pierotti MA; Pilotti S
Cancer; 2005 Jul; 104(1):159-69. PubMed ID: 15929122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]